(HealthDay)—A seven-day dose of metronidazole is associated with a reduced likelihood of being Trichomonas vaginalis-positive at test-of-cure compared with single-dose treatment, according to a study published online Oct. ...
Oct 17, 2018
0
1
Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania found that one in five newborn babies may not have measles antibodies passed down from their ...
Feb 3, 2023
2
90
New research published in this week's edition of The Lancet shows that malaria kills 1.2 million people worldwide each year: twice as many as previously thought. Furthermore, while many believe most malaria deaths occur in ...
Feb 2, 2012
11
0
Six months following molar pregnancies, women who have high (although decreasing) human chorionic gonadotropin (hCG) concentrations can be treated with chemotherapy. A study published Online First by The Lancet shows that ...
Nov 28, 2011
0
0
New research shows a drug commonly used to treat sickle cell anemia in adults reduces bouts of acute pain and a pneumonia-like illness, cuts hospitalization time and eases other symptoms of the disease in young patients. ...
May 12, 2011
0
0
A novel drug (pridopidine) that stabilises dopamine signalling in areas of the brain that control movement and coordination, appears well tolerated and warrants further study in patients with Huntington's disease (HD), a ...
Nov 7, 2011
0
0
Drug-resistant bacteria killed more than 33,000 people in the European Union in 2015, according to new research published this week warning that superbugs were "threatening modern healthcare."
Nov 6, 2018
0
128
Uncontrolled high blood pressure damages the brain's structure and function as early as young middle-age, and even the brains of middle-aged people who clinically would not be considered to have hypertension have evidence ...
Oct 31, 2012
0
0
(Medical Xpress) -- Patients who monitor their own treatment with warfarin or other blood-thinning drugs reduce their risk of developing blood clots by half, an Oxford University study has found.
Dec 1, 2011
0
0
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues as to why they experienced a high death rate of 33% when the coronavirus swept across Europe.
Jun 16, 2020
0
1
